🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

32 results for “Hua” Clear

  1. MB-102 DMID

    Hangzhou Zhongmei Huadong Pharmaceutical Co.,

    Kidney Diseases

    phase 3 small molecule completed

    1 trial

  2. BL-B01D1

    Sichuan Baili Pharmaceutical Co.,

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  3. BL-B01D1

    Sichuan Baili Pharmaceutical Co.,

    Cervical Cancer

    phase 2 small molecule active

    1 trial

  4. Bu-Yang-Huan-Wu Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ischemic Stroke

    phase 2 small molecule active

    1 trial

  5. HH-003(20mg/kg)

    Huahui Health

    Chronic Hepatitis Delta Virus Infection

    phase 2 mab completed

    1 trial

  6. PD-1 Inhibitor plus Chemotherapy

    Sichuan University

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  7. Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Oral Mucositis

    phase 2 small molecule active

    1 trial

  8. SI-B001

    Sichuan Baili Pharmaceutical Co.,

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  9. SKB103 for injection monotherapy

    Sichuan Provincial People's Hospital

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  10. Will receive HH-009 injection 20 mg/kg, Q3W

    Huahui Health

    Advanced or Unresectable Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  11. BL-M07D1

    Sichuan Baili Pharmaceutical Co.,

    Breast Cancer

    phase 1 small molecule active

    1 trial

  12. HB0017

    Huabo Biopharm Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  13. HMS5552

    Hua Medicine Limited

    Type II Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  14. Huafu Shengji Ointment

    Universal Integrated

    Diabetic Foot

    phase 1 small molecule active

    1 trial

  15. Jianpi Qinghua granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nonerosive Reflux Disease

    phase 1 small molecule active

    1 trial

  16. QT-019C

    Tianjin Huanhu Hospital

    Neuromyelitis Optica Spectrum Disorders

    phase 1 small molecule active

    1 trial

  17. Radiation: 18F-AlF-FAPi-04

    Sichuan Provincial People's Hospital

    Tumor, Solid

    phase 1 small molecule active

    1 trial

  18. rSIFN-co

    Sichuan Provincial People's Hospital

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule completed

    1 trial

  19. shenhuang granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 1 small molecule active

    1 trial

  20. Chinese Herb Huang-Chi-Wu-Wu-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracranial Arterial Stenosis

    approved small molecule active

    1 trial

  21. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial

  22. Mecobalamin

    Sichuan Provincial People's Hospital

    Sepsis

    approved small molecule active

    1 trial

  23. Xueshuanxinmaining tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  24. Buyang Huanwu Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Glaucoma

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources